Why Still in Neurosurgical Ward After Tumor Craniotomy?
NCT05288088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2023-11-18
Summary
The aim of this prospective observational study is to identify the specific reasons that prolong a hospital stay after elective tumor craniotomy. Optimal postoperative in-hospital stay is considered to be two days from surgery to discharge from the neurosurgical ward. However, a variable length of stay at a neurological department for follow-up of late recognized deficits of neurological consequences of the surgical procedure are common.
Conditions
- Surgery--Complications
- Brain Tumor
Interventions
- DIAGNOSTIC_TEST
-
No intervention
This is an observational study
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Martin K Sørensen, PhD · Department of Neuroanesthesiology, Rigshospitalet
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-12
- Primary Completion
- 2023-06-28
- Completion
- 2023-11-15
Countries
- Denmark
Study Locations
More Related Trials
-
Evaluation of Factors in Human Brain Tumors
NCT00001171 ·Status: COMPLETED
-
Surgical Resection of Latent Brain Tumors Prior to Recurrence
NCT04810871 ·Status: SUSPENDED ·Phase: NA
-
Long Term Survivors of High-grade Glioma and Their Caregivers
NCT02965144 ·Status: COMPLETED
-
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
NCT01417507 ·Status: COMPLETED
-
Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal
NCT02790294 ·Status: COMPLETED ·Phase: NA
-
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
NCT03861299 ·Status: RECRUITING ·Phase: NA
-
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
NCT02851706 ·Status: COMPLETED
-
Supratotal Resection for Gliomas Within Noneloquent Areas
NCT02676687 ·Status: UNKNOWN ·Phase: NA
-
Magnesium and Intraoperative Blood Loss in Meningioma Surgery
NCT03558516 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
NCT01668082 ·Status: RECRUITING ·Phase: NA
-
Awake vs. Asleep Craniotomy for Non-eloquent Gliomas
NCT03621748 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet for Recurrent Glioblastoma
NCT00575146 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
NCT04822688 ·Status: COMPLETED
-
Neurosurgical Outcome Network
NCT06724029 ·Status: RECRUITING
-
Risk Factors for Adult-Onset Brain Tumors
NCT00592865 ·Status: TERMINATED
-
General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas
NCT05485038 ·Status: SUSPENDED ·Phase: NA
-
Anterior Temporal Lobectomy in Temporal Glioblastoma
NCT07021339 ·Status: RECRUITING ·Phase: PHASE3
-
Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
NCT04553757 ·Status: ACTIVE_NOT_RECRUITING
-
PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
NCT02854228 ·Status: UNKNOWN
-
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
NCT05564949 ·Status: RECRUITING ·Phase: NA
-
Treatment Decision-making in Patients With Recurrent High-grade Glioma
NCT04013828 ·Status: COMPLETED
-
Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI
NCT02884947 ·Status: COMPLETED
-
Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over
NCT02892708 ·Status: COMPLETED ·Phase: PHASE3
-
Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
NCT07342699 ·Status: COMPLETED
-
Pituitary Tumor Surveillance: Pathogenic Correlation
NCT00599092 ·Status: RECRUITING